Skip to main content
Equibles
AKTS logo

AKTS · Aktis Oncology, Inc. · Held by Funds

Track AKTS — free

Use AKTS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AKTS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$15.73 -1.03 (-6.15%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$874.89M
Shares
55.62M
Volume · Oct 23 241.76K Avg daily vol (3M) 364.06K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of AKTS by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 4.39% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.19% 661,110
Index ETFs 3.20% 1,781,648
Active ETFs 0.00% 1,554
Active funds 9.24% 5,137,607
Unclassified 0.00% 0
All registered funds 13.63% 7,581,919
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding AKTS

110 fund positions
Fund Balance Value % of Fund Open
VANGUARD HEALTH CARE FUND 1,462,244 $32,271,725 0.08%
T. Rowe Price Small-Cap Stock Fund, Inc. 676,577 $21,806,077 0.23%
VANGUARD TOTAL STOCK MARKET INDEX FUND 585,135 $18,858,901 0.00%
iShares Russell 2000 ETF 545,302 $17,575,083 0.02%
Eventide Healthcare & Life Sciences Fund 507,000 $16,340,610 0.91%
T. Rowe Price Institutional Small-Cap Stock Fund 358,947 $11,568,862 0.23%
T. Rowe Price Health Sciences Fund, Inc. 333,745 $10,756,601 0.09%
VANGUARD EXTENDED MARKET INDEX FUND 209,816 $6,762,370 0.01%
T. Rowe Price New Horizons Fund, Inc. 196,735 $6,340,769 0.04%
Select Biotechnology Portfolio 283,355 $5,876,783 0.11%
BlackRock Health Sciences Opportunities Portfolio 266,503 $5,527,272 0.09%
T. Rowe Price Small-Cap Value Fund, Inc. 163,403 $5,266,479 0.05%
Fidelity Small Cap Index Fund 232,435 $5,129,840 0.02%
iShares Russell 2000 Growth ETF 133,328 $4,297,161 0.03%
Meridian Small Cap Growth Fund 105,570 $3,402,521 1.25%
VANGUARD RUSSELL 2000 INDEX FUND 105,593 $2,189,999 0.01%
Fidelity Extended Market Index Fund 97,084 $2,013,522 0.00%
iShares Russell 2000 Value ETF 59,825 $1,928,160 0.01%
BlackRock Health Sciences Term Trust 58,563 $1,887,485 0.18%
Schwab U.S. Small-Cap ETF 88,457 $1,834,598 0.01%
Master Small Cap Index Series 39,040 $1,258,259 0.02%
Schwab Small-Cap Index Fund 51,557 $1,137,863 0.02%
Fidelity Total Market Index Fund 41,318 $856,935 0.00%
BlackRock Health Sciences Trust 23,229 $748,671 0.13%
EQ/2000 Managed Volatility Portfolio 22,979 $740,613 0.02%
T. Rowe Price Health Sciences Portfolio 20,013 $645,019 0.09%
Nuveen Small Cap Blend Index Fund 28,152 $621,315 0.02%
Fidelity Nasdaq Composite Index Fund 28,570 $592,542 0.00%
Fidelity Series Total Market Index Fund 28,478 $590,634 0.00%
Health Sciences Portfolio 16,038 $516,905 0.14%
T. Rowe Price Spectrum Moderate Growth Allocation Fund 22,032 $456,944 0.01%
Fidelity Small Cap Growth Index Fund 13,687 $441,132 0.03%
LVIP State Street Small-Cap Index Fund 13,600 $438,328 0.02%
Small Cap Index Fund 10,724 $345,635 0.02%
VANGUARD BALANCED INDEX FUND 10,238 $329,971 0.00%
Polen 5Perspectives Small Growth Fund 14,852 $327,784 0.53%
Virtus Biotech Clinical Trials Etf 14,173 $312,798 0.67%
iShares Russell 3000 ETF 9,357 $301,576 0.00%
Nuveen Equity Index Fund 13,567 $299,424 0.00%
Fidelity Small Cap Value Index Fund 9,241 $297,837 0.01%
Schwab U.S. Broad Market ETF 13,916 $288,618 0.00%
Schwab Total Stock Market Index Fund 13,000 $286,910 0.00%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND 8,029 $258,775 0.00%
STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO 7,100 $228,833 0.01%
Global X Russell 2000 ETF 10,145 $223,900 0.02%
Health Sciences Trust 6,809 $219,454 0.09%
MetLife Russell 2000 Index Portfolio 6,754 $217,681 0.02%
VANGUARD RUSSELL 2000 GROWTH INDEX FUND 10,088 $209,225 0.01%
Small-Cap Index Portfolio 6,221 $200,503 0.02%
EQ/AB Small Cap Growth Portfolio 5,660 $182,422 0.01%
Showing 1–50 of 110 positions
Key facts CIK 2035832 CUSIP 01021M104 13F (30d) 10 filings 10 filers Visit website Investor relations